1 Several distinct fluid flow phenemena occur in solid tumours, including intravascular blood flow 2 and interstitial convection. To probe low-velocity flow in tumors resulting from raised interstitial 3 fluid pressure, we have developed a novel magnetic resonance imaging (MRI) technique 4 named convection-MRI. It uses a phase-contrast acquisition with a dual-inversion vascular 5 nulling preparation to separate intra-and extra-vascular flow. Here, we report the results of 6 experiments in flow phantoms, numerical simulations and tumor xenograft models to 7 investigate the technical feasibility of convection-MRI. We report a good correlation between 8 estimates of effective fluid pressure from convection-MRI with gold-standard, invasive 9 measurements of interstitial fluid pressure in mouse models of human colorectal carcinoma 10 and show that convection-MRI can provide insights into the growth and response to vascular-11 targeting therapy in colorectal cancers.
[1] 1 2 Here, v is fluid velocity, γ is the proton gyromagnetic ratio (267.513  10 6 rad s -1 T -1 ) and ΔM1 3 is the difference in first order velocity-encoding gradient moments (where venc = π/γΔM1 and 4 ΔM1 = 2G 2 ).
6
The convection-MRI sequence was used to measure fluid velocities in two directions, 7 corresponding to phase and readout imaging gradient orientations. Total scan duration was 8 25 minutes. In-plane fluid velocity vectors were constructed for each pixel and displayed using 9 in-house software written in Interactive Data Language (ITT, Boulder, Colorado) . A 10 streamlining algorithm (iVector) was used to visualise pathways between neighbouring 11 velocity vectors, which used points with low velocity relative to the distribution within the image 12 as seed points.
14
Mouse tumor models and in vivo MRI
15
All in vivo experiments were performed in accordance with the local ethical review panel, the 16 UK Home Office Animals Scientific Procedures Act (1986) and UK National Cancer Research 17 Institute (NCRI) guidelines (33). Six-week old MF1 nu/nu mice were injected subcutaneously 18 on the midline of the right flank, close to the hind limb (to minimize respiration motion during 19 imaging), with 510 6 SW1222 or LS174T cells.
21
MRI was performed following 10 to 15 days' growth (giving a tumor volume of approximately 22 0.6 cm 3 ). Immediately prior to scanning, anesthesia was induced in the mice with 3-4% 23 isoflurane carried in O2. Once anaesthesia was confirmed, mice were transferred to a bespoke 24 imaging cradle, in which anesthesia was maintained with 1.25 to 1.75% isoflurane, which was 25 delivered via a nose cone. Mice were positioned on their side, with tumor uppermost. Tumors 26 were liberally covered in dental paste (Charmflex, Dentkist, South Korea), to eliminate bulk 27 motion. When set (typically taking 2-3 minutes), the dental paste held the subcutaneous tumor To evaluate the ability of the 9.4 T MRI scanner to measure the velocity of fluid travelling at 3 velocities of the order of 1 -100 μm s -1 , an imaging phantom was constructed from a 5 mL 4 syringe, with an internal diameter of 11 mm (see Figure 1a ). This simple phantom provided 5 easily controllable fluid velocities, with coherent, laminar flow profiles, that can be compared 6 against convection-MRI velocity measurements, to inform subsequent in vivo experiments. A 7 syringe driver was used to inject water into the phantom, via silicon tubing that incorporated a 8 3 m loop within the scanner bore to allow the flowing water to become fully magnetised.
9
Convection-MRI data were acquired with no vascular nulling (i.e. equivalent to a purely 10 velocity-encoding sequence) from a sagittal slice through the chamber of the phantom. The 11 inflow rate of the phantom was varied between 0.007 and 6.85 mL min -1 (giving a theoretical 12 fluid velocity range of 1 to 1000 μm s -1 , assuming laminar flow). Convection-MRI data were 13 acquired in a cross-section across the phantom, without the vascular nulling preparation. venc 14 for these acquisitions was varied between 1000 and 5000 μm s -1 , applied in separate 15 acquisitions in the read and phase encoding directions.
17
Evaluation of the efficacy of vascular nulling 18 Phantom and in vivo experiments were performed to evaluate the ability of the convection-
19
MRI sequence to null the signal from fluid flowing within tumor blood vessels. Two sets of 20 images were acquired: the first without the vascular nulling (dual inversion) preparation, and 21 the second with vascular nulling. Taking the ratio of images acquired with and without vascular 22 nulling, referred to as the nulling ratio (nv), enabled vascular volume to be approximately 23 estimated (23).
25
Influence of the assumed value of blood T1 on vascular nulling in tumors
26
In a separate cohort of mice bearing SW1222 or LS174T tumors (n = 3 for each), the effect of 27 varying trec (equivalent to varying the assumed value of T1,blood) was investigated. Nulling ratio 28 maps were produced in each tumor for 17 values of trec, ranging from 100 to 5000 ms. The
29
average and standard deviation of the nulling ratio was estimated across the cohort and 30 plotted as a function of trec.
32
Estimation of apparent fluid pressure (Peff) from convection-MRI data 33 IFP was estimated from velocity vector fields using Darcy's law:
where K is the hydrostatic conductivity, v fluid velocity and P fluid pressure. To estimate P, 2 velocity vector fields, measured using convection-MRI, were numerically integrated using a 3 finite difference approach. To define absolute pressure, rather than relative changes in 4 pressure, estimates were offset by the average value at the periphery of the tumor, with the 5 assumption that the periphery of the tumor is in equilibrium with surrounding normal tissues 6 (34). We refer to this as the effective fluid pressure (Peff). Thus, a boundary condition for the 7 model was that the mean pressure at the periphery of the tumor is zero. For comparison, direct 8 measurement of IFP was performed using a clinical pressure transducer (Stryker, Kalamazoo,
9
Michigan, USA), modified to incorporate a 28G needle (34). Samples were acquired at 8 to 12 10 locations within each tumor, at depths corresponding to the convection-MRI imaging plane.
12
The influence of fluid exchange and incomplete vascular nulling on interstitial fluid velocity 13 measurements 14
To further evaluate nulling efficiency and the influence of nulled fluid entering the interstitium 15 on convection-MRI IFV estimates, a series of simulations were performed in the Interactive
16
Data Language (IDL, Excelis, Boulder, Colorado). A multi-compartment model of a vascular 17 tumor was constructed with a blood volume (fv) of 8%, intracellular volume (fic) 80% and the 18 volume of the extracellular extravascular space (EES, fees) 12%, reflecting those values 19 previously measured in SW1222 colorectal carcinoma mouse xenograft tumors (35) . A single 20 voxel within a section of tumor was modelled, with a slice thickness corresponding to that used 21 in the convection-MRI sequence.
23
Tumor blood vessels were modelled as randomly oriented cylinders. The radius of each 24 vessel, r, was generated by randomly drawing from a distribution of vessel radii previously 25 reported by Burrell et al (35) , which we fitted to an exponential probability distribution (p(r) = 26 0.15 exp(-70r)). The total blood vessel volume in each simulation was constrained to be within 27 10% of the average value (i.e. fv ranged from 7.2 to 8.8%). The pressure drop, ΔP, across 28 each vessel was fixed at 2 mm Hg mm -1 and blood viscosity, η, was fixed at 3.5×10 -3 N s m -2 .
29
Blood flow, F, in each vessel was calculated according to the Hagen-Poiseuille equation:
32 33 from which blood velocity, vv, was given by vv = F / d 2 , where d is the vessel diameter. The 34 change in signal phase induced by fluid flowing in each blood vessel, in the presence of 35 velocity-encoding gradients in the x, y or z directions (and with zero baseline phase), was 1 given by
where |vv| the magnitude of the blood velocity in the vessel, and α, β and γ are the angles of 7 the vessel, relative to the x, y and z imaging gradient axes, respectively. The total signal from 8 all blood vessels, for velocity-encoding gradients applied in the x-direction (the only direction 9 evaluated in the simulations, for simplicity), was then [5] 12 13 S0,v was fixed at unity and relaxation effects were not modelled. To model the effect of fluid 14 nulling in the vascular compartment a factor nv was introduced, which ranged from 0 and 1, 15 representing zero to complete nulling. nv was calculated by the fractional volume of nulled fluid 16 that replaced un-nulled fluid in blood vessels, at the end of the recovery time following the dual 17 inversion pulses. This was given by
where a is the thickness of the imaging slice (1 mm) and b is the thickness of the slice-selective 22 inversion pulse (3 mm).
24
Interstitial fluid velocity was varied between 1 and 100 μm s -1 and was directed along the x-25 axis, for simplicity. By analogy with the vascular signal, the signal from the interstitial 26 compartment, for velocity-encoding gradients applied in the x direction, was and S0,ees was fixed at unity. Simulated nulling of EES fluid was 1 performed explicitly, with nees ranging from 0 to 1. The total MR signal S was then given by
6 7 1000 Monte Carlo iterations were performed, within each of which a different distribution of 8 blood vessels (drawn from the parent distribution described above) was simulated. As a final 9 step, Gaussian noise was added to each set of simulated data to give signal-to-noise 10 characteristics comparable to those found in in vivo data. The phase of data simulated with 11 velocity-encoding gradients applied in the x-direction was then estimated, converted into a 12 velocity estimate, and compared with the simulated EES velocity.
14
Two sets of simulations were performed. Firstly, the effect of nulled fluid entering the 15 interstitium was investigated by varying nees between 0 (no nulling) and 1 (complete nulling).
16
Intravascular nulling, nv, was calculated according to Eq. 5, allowing the theoretical efficacy of 17 vascular nulling to also be determined. In the second set of simulations, to ascertain the 18 influence of un-nulled fluid in the vascular compartment on convection-MRI measurements, nv 19 was explicitly scaled between 0 and 1, and nees was fixed at 0. 
26
MRI acquisition). FAIR-ASL does not require a labelling artery to be identified, and instead 27 uses two acquisitions with different inversion preparations: the first, a global inversion pulse, 28 inverts all spins; the second a localized, slice-selective pulse inverts spins within the tissue of 29 interest (a 3 mm slice thickness was used here). The difference between these two signals 30 can be used to measure perfusion, and here regional perfusion maps were calculated as 31 described by Belle et al. (38) , with an assumed blood-partition constant of 0.9. As for 32 convection-MRI measurements, the T1 longitudinal relaxation time of blood was assumed to 33 be 1900 ms (39). FAIR-ASL data were acquired in a single slice located in the same position 34 as convection-MRI data. [9] 9 10 on a pixel-by-pixel basis, using a Bayesian maximum a posteriori approach that takes into 11 account the Rician distribution of magnitude MRI data (40). b is the b-value associated with 12 each diffusion-weighted acquisition, and S is the acquired signal magnitude for each pixel.
13
Maps of each fitted parameter (the apparent diffusion coefficient (ADC) and S0) were 14 generated.
16
Dynamic contrast-enhanced MRI 17 Gadolinium-DTPA (Magnevist, Bayer, Leverkusen, Germany) was prepared to a 18 concentration of 0.2 mM (factor of 10 dilution) and transferred to a 50 mL Falcon tube. This 19 was placed in a power injector (Harvard Instruments, Cambourne, UK), positioned inside the 20 scanner room, with a 2 m tube attached, feeding into an 18 G plastic cannula. The dead 21 volume of the tubing was primed with contrast agent and the cannula positioned within the 22 intraperitoneal cavity. Contrast agent was infused at 0.005 mmol kg -1 min -1 for the duration of 23 the scan (total dose 0.2 mMol kg -1 ). A gradient-echo sequence was used to acquire three- with the tumor vasculature. Casting was performed immediately following MRI. Briefly, the 35 heart was exposed and a blunted 25G butterfly cannula was inserted through the heart and 36 into the ascending aorta. 10 mL of saline was injected through the cannula using a syringe 37 1 material (Microfil, Flowtech, Boston, USA) was injected via the same cannula at 60 mL hr -1 .
2
The microfil used was colored yellow and could be seen entering the vascular bed of the 3 subcutaneous tumors; perfusion of resin was continued until no further coloration of tumor 4 vasculature occurred (typically around 25 mL of resin in total, of which a significant proportion 5 is lost as waste). Following perfusion, the resin was allowed to completely polymerise, which 6 took approximately two hours. Tumors were then carefully resected from the mouse carcass, 7 mounted in chlorine-free plastic food wrap inside a 20 mL syringe (Sigma-Aldrich, Gillingham, 8 Dorset), with plunger removed, and sent for micro-CT. and was greatest in a channel through the centre of the phantom (Figure 1b) .
27
For venc of 2000 and 5000, velocity measurements were significantly correlated with theoretical 28 velocity predictions (p<0.01, Spearman's rho), for a range of physiological inflow values 29 (Figure 1) . At lower venc values, aliasing occurred at higher velocity values (resulting in 30 significantly lower velocity estimates; denoted by arrows on Figure 1c ), and signal crushing 31 by velocity gradients (particularly at venc ≤ 500 µm s -1 ). At the largest inflow rate (6.85 mL min -32 1 , theoretical velocity 1000 µm s -1 ), significant spatial wrapping was found in raw velocity 33 encoded data, for the majority of venc values used, so this data point was disregarded.
35
Whilst, for venc ≥ 2000 µm s -1 , convection-MRI velocity measurements were significantly 36 correlated with theoretical estimates, they displayed a slight overestimation (15 ± 23 %, based 37 1 measured before the signal approached the noise background level, was 0.07 mL min -1 2 (corresponding to a velocity of 20 m s -1 ).
4
Evaluation of vascular nulling in tumors 5
The convection-MRI sequence was next evaluated in vivo, using subcutaneous mouse tumor 6 xenograft models (SW1222 and LS174T human colorectal carcinoma cell lines). Our first 7 objective was to assess the efficacy of the vascular nulling component. As the preparation 8 aims to destroy the signal from fluid flowing in blood vessels, taking the ratio of images 9 acquired with and without vascular nulling (the nulling ratio) allowed us to approximately 10 estimate the vascular blood volume (23). In subcutaneous colorectal xenograft models 11 (SW1222 and LS174T, n = 4 for each), the measured nulling ratio ranged from 0 to 80% and 12 was heterogeneously distributed throughout the tumors (Figure 2a ). On average, vascular 13 nulling induced a decrease in signal of 18% in SW1222 and 13% in LS174T tumors, a 14 difference that was significantly different (p < 0.05, Mann-Whitney). No nulling was observed 15 in a static agar phantom, as expected, due to the absence of flowing fluid (Figure 2a ).
17
Plotting the mean nulling ratio as a function of the assumed blood longitudinal relaxation time 18 (T1,blood), from in vivo experiments in SW1222 tumors (n = 4), revealed a plateau centred at 19 1900 ms at which the signal decrease caused by nulling was maximal (Figure 2b ), suggesting 20 that vasculaing nulling was most effective for an assumed T1,blood = 1900 ms (and so was used 21 throughout the remainder of the study).
23
Measurement of fluid velocity in tumors 24 25
Complete sets of convection-MRI data (i.e. with both vascular nulling and velocity encoding) 26 were next acquired in SW1222 and LS174T tumors (n = 6 for both) (Figure 3) velocities in blood vessels in the range of 0.2 to 15 mm s -1 , which contrasts with the much 9 slower fluid velocities in the interstitium (explicitly varied between 1 and 100 μm s -1 ).
11
In the first set of simulations, it was found that nv was consistently greater than 99.9%, for 12 each set of parameter values, suggesting that vascular nulling in this type of tumor is feasible.
13
A fraction of the interstitial fluid was explicitly nulled to represent leakage of nulled fluid from 14 the vasculature, and unintentional nulling of the interstitial fluid signal. Under these conditions,
15
the accuracy of IFV measurements was unaffected by the nulling of interstitial fluid ( Figure   16 4b), but precision progressively decreased with increased nulling (evidenced by the increasing 17 standard error shown in Figure 4b ). This loss of precision was caused by the decrease in 18 signal-to-noise ratio resulting from the nulling, although the value of the simulated IFV had no 19 influence on the magnitude of this effect.
21
In the second set of simulations, a progressive, incomplete nulling was imposed on the 22 vascular fluid. It was found that both the accuracy and precision of IFV measurements became 23 poorer as the fractional nulling of vascular fluid decreased (Figure 4c) . The mean relative 24 error in velocity measurements was 15%, 50% and 115% for 95%, 80% and 50% vascular 25 nulling, respectively. As shown in Figure 4c , incomplete vascular nulling introduced a 26 progressive offset to velocity measurements, but the gradient of each line is constant. Figure 5c ). On average, 1 those from the pressure transducer, and this over-estimation was larger at low IFP values. In 2 these calculations, a fixed value was used for the hydrostatic conductivity (4.13×10 -8 cm 2 mm 3 Hg -1 s -1 (4)).
5
Comparison of tumor blood flow and fluid velocity distributions 6 Next, the coupling of intravascular and interstitial flow was probed, in a set of experiments in 7 which measurements of tumor fluid velocity were acquired with convection-MRI, alongside 8 measurements of vascular perfusion from arterial spin labelling (ASL) MRI. These were 9 accompanied by high resolution images blood vessels acquired ex vivo from vascular casts at 10 high spatial resolution (6 μm), with micro-CT.
12
Our first observation was that regions of high vascular perfusion (Figure 6a 
7
The relationship between vascular perfusion and effective fluid pressure during tumor growth 8
The mechanisms that initiate and maintain raised IFP in tumors are of particular interest, and 9 so we performed a further experiment that aimed to measure fluid velocity, effective fluid 10 pressure and perfusion in tumors during growth from a small size (10 days following 11 inoculation, defined as day 0), for a total of 10 days (Figure 7a) . We found no significant 12 difference in the mean growth rates for SW1222 and LS174T tumors, which were measured is generally more evident in LS174T tumors than in SW1222 tumors, it might be expected that 18 the measured apparent diffusion coefficient (ADC) would be correspondingly larger; however,
19
there was no significant difference between the two tumor types, which is consistent with our 20 previous measurements (30).
22
Assessment of response to therapy with a vascular disrupting agent
23
At the end of the growth experiment, and immediately following the final MRI measurement,
24
we administered a single dose of the vascular disrupting agent CA4P (100 mg kg -1 ) to all mice.
25
Previous studies have shown that this rapidly induces vascular occlusion and haemorrhage 26 (41), and a corresponding change in perfusion and IFP (42). With this in mind, we measured 27 the change in perfusion, Peff and fluid velocity at 24 hours following dosing. As expected, tumor 28 volume did not change significantly with CA4P dosing, whilst perfusion significantly decreased 29 (p<0.01 in LS174T and p<0.05 in SW1222). Fluid velocity significantly increased in LS174T 30 tumours (p < 0.05)) and Peff significantly decreased in SW1222 tumors (p < 0.05) (Figure 7c ).
31
Tumor ADC significantly increased at 24 hours after dosing, in both tumor types, presumably 32 due to the onset of necrosis (p < 0.05, data not shown). achieve this a number of assumptions associated with the measurement would need to be 5 validated, and we aimed to evaluate the most significant of these in this study. We then used 6 convection-MRI to study low-velocity fluid flow in tumor xenograft models, which appeared to 7 reveal macroscopic flow patterns that were consistent with the flow of fluid through the tumor 8 interstitium, albeit at velocities greater than those normally associated with interstitial flow.
10
In tumor xenograft models of human colorectal cancer, we calculated mean fluid velocity 
25
These observations were further explored through Monte Carlo simulations of a SW1222 26 tumors, which predicted vascular nulling of greater than 99.9%, for all sets of physiological 27 parameters considered. They also showed that un-nulled vascular fluid can, in principle, be 28 entirely replaced by nulled fluid within the recovery time trec between vascular nulling and 29 velocity encoding. In the simulations, straight tumor vessels were modelled, whilst real tumor 30 vessels are likely to take more tortuous paths, thereby potentially explaining the disparity 31 between our simulation results and the fluid velocities measured in vivo (43). Sensitivity to 32 these slower flowing components (and improved specificity towards interstitial flow) could 33 therefore potentially be achieved by improving vascular nulling for slow-flowing blood, and 34 increasing the acquisition venc.
35 36 1 volume were also derived by comparing nulled and un-nulled images. This analysis provided 2 blood volume estimates that were greater than, but of the order of the microvascular density 3 previously reported for these tumor types. Previous studies provide average blood volumes of 4 between 9 (44) and 25% (30) for SW1222 and 8 (30) to 9% (45) for LS174T tumors, whereas 5
we measured an average percentage vascular nulling of 18% and 13% for SW1222 and 6 LS174T tumors, respectively. The largest blood volume values were measured at the tumor 7 periphery (of the order of 80%), where vessels tend to be larger and more concentrated (29), 8 which demonstrates the ability of convection-MRI to capture the spatial heterogeneity of tumor 9 vasculature. These data could therefore act as a useful complement to the convection-MRI 10 acquisition, although requires the acquisition of the additional un-nulled image.
12
Despite our velocity measurements being greater than those previously reported in the 13 literature, we still found a significant correlation between Peff (derived from the spatial 14 derivative of velocity measurements) and measurements of IFP measured directly with a 15 pressure transducer, although with a 26% overestimation (Figure 5c) . We used Darcy's Law
16
to quantify pressure from velocity vector fields, which is widely used in the modelling of fluid 17 dynamics in biological tissue. It is valid for systems with a low Reynolds number which, in 18 tumors, is typically much less than 1 (46). When estimating absolute pressure from velocity 19 vector fields, pressure boundary conditions are required, and here we assumed that the mean 20 interstitial pressure at the periphery of tumors was maintained at atmospheric pressure (34).
21
Equally, we used a fixed value for the hydrostatic conductivity of tumor tissue, K. K provides 22 a linear scaling to pressure estimates (as per Darcy's Law in equation 2), and so errors 23 associated with this value will therefore introduce a linear offset into pressure estimates. As K 24 can only currently be measured by invasive means, use of a fixed value is presently the only 25 available solution. Our assessment of repeatability and reproducibility (36% and 59%) were 26 slightly larger, but of the order of those measured for other MRI techniques (e.g. 13% -62%
27
for diffusion MRI (47) and 8.9 to 18.2 % for dynamic contrast-enhanced MRI (48)). This 28 variation could potentially be reflective of true physiological changes over short timeframes.
30
We next probed the relationship between microvascular perfusion and interstitial fluid 31 pressure, which has not been extensively studied, mainly due to a lack of available, non-32 invasive techniques. Our measurements, acquired over a period of ten days of tumor growth, 33 revealed differences in the microenvironments of two colorectal tumor types. We found that 34 perfusion on average decreased with tumor volume, whilst effective fluid pressure increased,
35
which is in agreement with previous studies (20, 49) . Both low vascular perfusion and raised 36 IFP can act as a barrier to drug delivery, our combined approach would allow these properties to be probed simultaneously and monitored longitudinally. Generally, LS174T tumors are more 1 necrotic than SW1222 tumors, at 59 ± 4 % and 10 ± 3 %, respectively, in fully-grown tumors 2 (50), and which likely increases to these levels throughout tumor growth. Large regions of 3 central necrosis occurs at 24 hours following dosing with CA4P (51). However, the presence 4 of necrosis should not affect the convection-MRI acquisition (instead, it could be of interest to 5 study further, to investigate the influence of necrosis on interstitial fluid pressure and drug 6 delivery).
8
We have also shown here that ASL and convection-MRI, in combination, can be used to 9 assess response to the vascular disrupting agent CA4P. 
7
The assumed value of T1,blood is used to set the recovery time following the inversion 8 preparation (trec = ln(2) T1,blood). The graph shows that, for a range of T1,blood of 1600 to 2500 9 ms, the nulling ratio is maximal. At lower values, the nulling is lower as the signal from blood 10 has not recovered to a null point; at larger values, the signal has recovered past the null. The 11 plateau represents a region where the signal from blood is near to or at the null point and has 12 sufficient time to flow into and replace unlabelled blood within the imaging slice. in each parameter at 24 hours following treatment with CA4P. Tumor volume did not 1 significantly change with treatment, whilst in LS174T tumors, perfusion decreased and 2 interstitial fluid speed and ADC increased. In SW1222 tumors, perfusion and Peff significantly 3 decreased and ADC significantly increased. Error bars represent the standard error in the 4 mean; ** denotes p<0.01, * denotes p<0.05.
